- Network Pharmacology‐Based Identification of the Mechanisms of Shen‐Qi Compound Formula in Treating Diabetes Mellitus
Zhipeng Hu et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef - Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
Lvzhuo Zhang et al, 2024, Phytotherapy Research CrossRef - Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
Ming-Fei Guo et al, 2020, Journal of Diabetes Research CrossRef - Emerging Applications of Metabolomics to Assess the Efficacy of Traditional Chinese Medicines for Treating Type 2 Diabetes Mellitus
Yumeng Zhang et al, 2021, Frontiers in Pharmacology CrossRef - An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies
Min-Han Chi et al, 2022, Frontiers in Pharmacology CrossRef - Implication of the MAPK Signalling Pathway in the Pathogenesis of Diabetic Nephropathy
Jéssica Barletto Sousa Barros et al, 2019, EMJ Diabetes CrossRef - Combination of Astragalus membranaceus and Panax notoginseng as Main Components in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta‐Analysis
Xiaoning An et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef - Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review
Min Su et al, 2023, Frontiers in Immunology CrossRef